Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraperitoneal Aerosolization of Albumin-stabilized Paclitaxel Nanoparticles for Stomach, Pancreas, Breast and Ovarian Cancer

NCT03304210 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT03304210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03304210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraperitoneal Aerosolization of Albumin-stabilized Paclitaxel Nanoparticles for Stomach, Pancreas, Breast and Ovarian Cancer
Lead sponsor
University Hospital, Ghent
Phase
Phase 1
Overall status
Completed
Start date
September 16, 2017
Completion date
May 6, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer stage iiib, breast cancer stage iiic, breast cancer stage iv, ovarian cancer stage iiib, ovarian cancer stage iiic, ovarian cancer stage iv, pancreas cancer, stage iii, pancreas cancer, stage iv, peritoneal carcinomatosis, stomach cancer stage iii, stomach cancer stage iv with metastases